Solvemed Group
At Solvemed Group, we believe in challenging the status quo of neurological care. Our founders experienced first-hand the grave consequences of poor diagnostic standards in neurodegenerative diseases. With the primary focus in Parkinson’s disease, we leverage our proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools. In everything we do, we put the needs of patients and healthcare professionals first. We also happen to revolutionise dru...
read more
At Solvemed Group, we believe in challenging the status quo of neurological care. Our founders experienced first-hand the grave consequences of poor diagnostic standards in neurodegenerative diseases. With the primary focus in Parkinson’s disease, we leverage our proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools. In everything we do, we put the needs of patients and healthcare professionals first. We also happen to revolutionise drug discovery as our biomarkers enable disease-modifying drugs. We respond to the unmet needs of neurological patients by providing reliable, accurate, early diagnostics and monitoring tools for better quality care and treatment outcomes. Our work has the potential to improve healthcare systems by optimising relevant care pathways and reducing the financial burden imposed by inadequate diagnostics. Through our proprietary medical data repositories, we work with our biopharmaceutical industry partners driving clinical trial efficiency and making first-in-class disease-modifying drugs possible. Everything we do is strongly embedded in world-class science. Our global team of renowned scientists and technology experts works closely with clinical researchers from top research institutions, such as Oxford University, University College London, Harvard Medical School and Duke University, among other.
show less
Industry | Medical Devices | |
Location | Oxford, Oxfordshire, United Kingdom | |
Employees | 18 | |
Founded | 2019 |
HQ | 273 Iffley Road | |
Funding | 770,000 USD | |
Competitors | Medtronic, Stryker, Fresenius Medical Care, Boston Scientific, Bd, Baxter International ..., |
Industry | Medical Devices | |
Location | Oxford, Oxfordshire, United Kingdom | |
Employees | 18 | |
Founded | 2019 | |
linkedin.com/company/solvemed-group | ||
HQ | 273 Iffley Road | |
Funding | 770,000 USD |
Top Competitors for Solvemed Group
Solvemed Group Questions
Where are Solvemed Group's headquarters?
Solvemed Group's headquarters are in 273 Iffley Road
How many employees are working in Solvemed Group right now?
Solvemed Group has
18 employees.
View the Email and Phone Numbers for all 18 working at Solvemed Group.
What is Solvemed Group's industry?
Solvemed Group's industry is
Medical Devices
Who are Solvemed Group's top competitors?
Solvemed Group's top competitors are
Medtronic
,
Stryker
,
Fresenius Medical Care
,
Boston Scientific
,
Bd
,
Baxter International Inc.
What are Solvemed Group's categories?
Solvemed Group's categories are Artificial Intelligence, Machine Learning, Medical Device
What is Solvemed Group's location?
Solvemed Group's location is
Oxford, Oxfordshire, United Kingdom
When was Solvemed Group's founded?
Solvemed Group's founding year is 2019
What is Solvemed Group's funding?
Solvemed Group's funding is 770,000 USD
What is Solvemed Group's current status?
Solvemed Group's current status is operating